John F. Young - 31 Mar 2025 Form 4 Insider Report for EXELON CORP (EXC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Apr 2025, 14:29:39 UTC
Prior SEC filing
03 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
David T Skinner, attorney-in-fact for John F Young

Key filing fact

John F. Young filed Form 4 for EXELON CORP (EXC) on 02 Apr 2025.

Key facts

  • This page summarizes John F. Young's Form 4 filing for EXELON CORP (EXC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Apr 2025, 14:29.

Change

  • Previous filing in this sequence was filed on 03 Jan 2025.
  • Current net transaction value: +$41,229.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXC transaction

Common stock- deferred stock units

Award

Transaction value
$41,229
Shares
+933
Change %
+3%
Price
$44.19
Shares after
32,286
Date
31 Mar 2025
Ownership
By Exelon Corp. Directors Deferred Stock Unit Plan
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Balance includes 281 additional shares acquired through automatic dividend reinvestment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .